Tianshui Zhongxing Bio-Tech's Q1 profit surges 38.72%

Tianshui Zhongxing Bio-Technology (SZSE:002772) announced a strong first quarter for 2025, with operating revenue reaching CNY 472,639,729.59. Net profit attributable to shareholders increased by 38.72% year-over-year, reaching CNY 48,200,213.87. Net profit after deducting non-recurring gains and losses attributable to shareholders also saw a significant rise of 57.01%, totaling CNY 45,654,217.18. Basic and diluted earnings per share both rose to 0.1284. The company's total assets stood at CNY 6,386,589,455.41, with shareholders' equity at CNY 3,347,763,088.49. The company attributes the increased profit to streamlined production and reduced raw material costs.